Novartis Ag (NVS) Current Leases (2019 - 2025)
Historic Current Leases for Novartis Ag (NVS) over the last 7 years, with Q4 2025 value amounting to $1.7 billion.
- Novartis Ag's Current Leases rose 567.6% to $1.7 billion in Q4 2025 from the same period last year, while for Dec 2025 it was $1.7 billion, marking a year-over-year increase of 567.6%. This contributed to the annual value of $1.7 billion for FY2025, which is 567.6% up from last year.
- As of Q4 2025, Novartis Ag's Current Leases stood at $1.7 billion, which was up 567.6% from $1.6 billion recorded in Q3 2025.
- Novartis Ag's Current Leases' 5-year high stood at $1.7 billion during Q2 2021, with a 5-year trough of $275.0 million in Q4 2021.
- Moreover, its 5-year median value for Current Leases was $1.6 billion (2022), whereas its average is $1.5 billion.
- As far as peak fluctuations go, Novartis Ag's Current Leases crashed by 8400.23% in 2021, and later skyrocketed by 45927.27% in 2022.
- Over the past 5 years, Novartis Ag's Current Leases (Quarter) stood at $275.0 million in 2021, then soared by 459.27% to $1.5 billion in 2022, then grew by 3.9% to $1.6 billion in 2023, then fell by 1.88% to $1.6 billion in 2024, then increased by 5.68% to $1.7 billion in 2025.
- Its Current Leases was $1.7 billion in Q4 2025, compared to $1.6 billion in Q3 2025 and $1.6 billion in Q2 2025.